These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 23941778)

  • 1. Post-acute serum eosinophil and neutrophil-associated cytokine/chemokine profile can distinguish between patients with neuromyelitis optica and multiple sclerosis; and identifies potential pathophysiological mechanisms - a pilot study.
    Michael BD; Elsone L; Griffiths MJ; Faragher B; Borrow R; Solomon T; Jacob A
    Cytokine; 2013 Oct; 64(1):90-6. PubMed ID: 23941778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristic cerebrospinal fluid cytokine/chemokine profiles in neuromyelitis optica, relapsing remitting or primary progressive multiple sclerosis.
    Matsushita T; Tateishi T; Isobe N; Yonekawa T; Yamasaki R; Matsuse D; Murai H; Kira J
    PLoS One; 2013; 8(4):e61835. PubMed ID: 23637915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased plasma levels of epithelial neutrophil-activating peptide 78/CXCL5 during the remission of Neuromyelitis optica.
    Yang T; Wang S; Zheng Q; Wang L; Li Q; Wei M; Du Z; Fan Y
    BMC Neurol; 2016 Jul; 16():96. PubMed ID: 27401736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromyelitis optica IgG serostatus in fulminant central nervous system inflammatory demyelinating disease.
    Magaña SM; Pittock SJ; Lennon VA; Keegan BM; Weinshenker BG; Lucchinetti CF
    Arch Neurol; 2009 Aug; 66(8):964-6. PubMed ID: 19667216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overlapping CNS inflammatory diseases: differentiating features of NMO and MS.
    Juryńczyk M; Craner M; Palace J
    J Neurol Neurosurg Psychiatry; 2015 Jan; 86(1):20-5. PubMed ID: 25248365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status.
    Yoshimura S; Isobe N; Matsushita T; Yonekawa T; Masaki K; Sato S; Kawano Y; Kira J;
    J Neurol Neurosurg Psychiatry; 2013 Jan; 84(1):29-34. PubMed ID: 23038741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures.
    Jarius S; Paul F; Franciotta D; Ruprecht K; Ringelstein M; Bergamaschi R; Rommer P; Kleiter I; Stich O; Reuss R; Rauer S; Zettl UK; Wandinger KP; Melms A; Aktas O; Kristoferitsch W; Wildemann B
    J Neurol Sci; 2011 Jul; 306(1-2):82-90. PubMed ID: 21550068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct serum cytokine profiles in neuromyelitis optica and multiple sclerosis.
    Wang KC; Lee CL; Chen SY; Chen JC; Yang CW; Chen SJ; Tsai CP
    J Interferon Cytokine Res; 2013 Feb; 33(2):58-64. PubMed ID: 23398365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood-brain barrier disruption is more severe in neuromyelitis optica than in multiple sclerosis and correlates with clinical disability.
    Tomizawa Y; Yokoyama K; Saiki S; Takahashi T; Matsuoka J; Hattori N
    J Int Med Res; 2012; 40(4):1483-91. PubMed ID: 22971500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct functionality of neutrophils in multiple sclerosis and neuromyelitis optica.
    Hertwig L; Pache F; Romero-Suarez S; Stürner KH; Borisow N; Behrens J; Bellmann-Strobl J; Seeger B; Asselborn N; Ruprecht K; Millward JM; Infante-Duarte C; Paul F
    Mult Scler; 2016 Feb; 22(2):160-73. PubMed ID: 26540731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.
    Misu T; Fujihara K; Kakita A; Konno H; Nakamura M; Watanabe S; Takahashi T; Nakashima I; Takahashi H; Itoyama Y
    Brain; 2007 May; 130(Pt 5):1224-34. PubMed ID: 17405762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuromyelitis optica.
    Matiello M; Jacob A; Wingerchuk DM; Weinshenker BG
    Curr Opin Neurol; 2007 Jun; 20(3):255-60. PubMed ID: 17495617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased occurrence of anti-AQP4 seropositivity and unique HLA Class II associations with neuromyelitis optica (NMO), among Muslim Arabs in Israel.
    Brill L; Mandel M; Karussis D; Petrou P; Miller K; Ben-Hur T; Karni A; Paltiel O; Israel S; Vaknin-Dembinsky A
    J Neuroimmunol; 2016 Apr; 293():65-70. PubMed ID: 27049564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent insights into the pathology of multiple sclerosis and neuromyelitis optica.
    Wegner C
    Clin Neurol Neurosurg; 2013 Dec; 115 Suppl 1():S38-41. PubMed ID: 24321153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic value of aquaporin-4 antibody in patients of inflammatory demyelinating diseases in central nervous system].
    Yang Y; Wu WP; Huang DH; Wu L
    Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(43):3032-5. PubMed ID: 23328372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced IL-6 production in aquaporin-4 antibody positive neuromyelitis optica patients.
    Içöz S; Tüzün E; Kürtüncü M; Durmuş H; Mutlu M; Eraksoy M; Akman-Demir G
    Int J Neurosci; 2010 Jan; 120(1):71-5. PubMed ID: 20128675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuromyelitis optica: not a multiple sclerosis variant.
    Barnett MH; Sutton I
    Curr Opin Neurol; 2012 Jun; 25(3):215-20. PubMed ID: 22487568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for humoral autoimmunity in neuromyelitis optica.
    Wingerchuk DM
    Neurol Res; 2006 Apr; 28(3):348-53. PubMed ID: 16687064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.
    Paul F; Jarius S; Aktas O; Bluthner M; Bauer O; Appelhans H; Franciotta D; Bergamaschi R; Littleton E; Palace J; Seelig HP; Hohlfeld R; Vincent A; Zipp F
    PLoS Med; 2007 Apr; 4(4):e133. PubMed ID: 17439296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Connexin 43 astrocytopathy linked to rapidly progressive multiple sclerosis and neuromyelitis optica.
    Masaki K; Suzuki SO; Matsushita T; Matsuoka T; Imamura S; Yamasaki R; Suzuki M; Suenaga T; Iwaki T; Kira J
    PLoS One; 2013; 8(8):e72919. PubMed ID: 23991165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.